{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:19:53Z","timestamp":1771064393819,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejps.2025.107159","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T02:36:51Z","timestamp":1749263811000},"page":"107159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Archaeosomal nanocarriers improve pharmacokinetics and bioavailability of vancomycin after oral administration"],"prefix":"10.1016","volume":"212","author":[{"given":"Viktor","family":"Sedlmayr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Quehenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wurm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikko","family":"Gynther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Vieth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"D\u00fcrr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Gesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Spadiut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Fricker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8616-5599","authenticated-orcid":false,"given":"Philipp","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107159_bib0001","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1080\/17435889.2024.2377063","article-title":"Recent advances in nanostructured delivery systems for vancomycin","volume":"19","author":"Ansari","year":"2024","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejps.2025.107159_bib0002","first-page":"14304","article-title":"Structure\u2013function relationships in pure archaeal bipolar tetraether lipids","author":"Bhattacharya","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejps.2025.107159_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33826-9","article-title":"Studies on the metabolism and degradation of vancomycin in simulated in vitro and aquatic environment by UHPLC-Triple-TOF-MS\/MS","volume":"8","author":"Cao","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2025.107159_bib0004","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41598-020-57776-3","article-title":"The antibiotic vancomycin induces complexation and aggregation of gastrointestinal and submaxillary mucins","volume":"10","author":"Dinu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2025.107159_bib0005","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-010-0130-x","article-title":"Phospholipids and lipid-based formulations in oral drug delivery","volume":"27","author":"Fricker","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107159_bib0006","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.apsb.2018.06.005","article-title":"Adapting liposomes for oral drug delivery","volume":"9","author":"He","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejps.2025.107159_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/nano.70010","article-title":"Liposomes containing tetraether lipids and cell-penetrating peptides as platform technology for oral delivery of peptides: a comparative study on GLP-1 analogs","author":"Herbster","year":"2025","journal-title":"Nano Sel."},{"key":"10.1016\/j.ejps.2025.107159_bib0008","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/pharmaceutics11030129","article-title":"Challenges and recent progress in oral drug delivery systems for biopharmaceuticals","volume":"11","author":"Homayun","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107159_bib0009","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejps.2025.107159_bib0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejps.2016.12.036","article-title":"Archaeal lipids in oral delivery of therapeutic peptides","volume":"108","author":"Jacobsen","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107159_bib0011","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpharm.2015.07.026","article-title":"Liposomes containing lipids from Sulfolobus islandicus withstand intestinal bile salts: an approach for oral drug delivery?","volume":"493","author":"Jensen","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107159_bib0012","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.3109\/10717544.2015.1019653","article-title":"Archaeosomes: an excellent carrier for drug and cell delivery","volume":"23","author":"Kaur","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107159_bib0013","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/jphp.13329","article-title":"Scalable solvent-free production of liposomes","volume":"72","author":"Khadke","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107159_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119912","article-title":"Advances in drug delivery systems: work in progress still needed?","volume":"590","author":"Laffleur","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107159_bib0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bbrc.2010.03.041","article-title":"Investigation of archaeosomes as carriers for oral delivery of peptides","volume":"394","author":"Li","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2025.107159_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004833","article-title":"Archaea in and on the human body: health implications and future directions","volume":"11","author":"Lurie-Weinberger","year":"2015","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.ejps.2025.107159_bib0017","first-page":"21","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the american society of health-system pharmacists, the infectious diseases society of America, and the society of infectious diseases pharmacists","volume":"31","author":"Martin","year":"2010","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.ejps.2025.107159_bib0018","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2174\/156720111795256138","article-title":"M cells prefer archaeosomes: an In vitro\/In vivo snapshot upon oral gavage in rats","volume":"8","author":"Morilla","year":"2011","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107159_bib0019","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/acs.langmuir.7b03893","article-title":"Phospholipase A2 -induced degradation and release from lipid-containing polymersomes","volume":"34","author":"Mumtaz Virk","year":"2018","journal-title":"Langmuir"},{"key":"10.1016\/j.ejps.2025.107159_bib0020","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/ejlt.201300409","article-title":"Matrix liposomes: a solid liposomal formulation for oral administration","volume":"116","author":"Pantze","year":"2014","journal-title":"Euro. J. Lipid Sci. Tech."},{"key":"10.1016\/j.ejps.2025.107159_bib0021","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/jps.24215","article-title":"Improved oral bioavailability of Human growth hormone by a combination of liposomes containing bio-enhancers and tetraether lipids and omeprazole","volume":"103","author":"Parmentier","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107159_bib0022","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2011.05.066","article-title":"Oral peptide delivery by tetraether lipid liposomes","volume":"415","author":"Parmentier","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107159_bib0023","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00792-020-01165-1","article-title":"The influence of the specific growth rate on the lipid composition of sulfolobus acidocaldarius","volume":"24","author":"Quehenberger","year":"2020","journal-title":"Extremophiles"},{"key":"10.1016\/j.ejps.2025.107159_bib0024","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/SLA.0000000000001923","article-title":"Intravenous versus oral antibiotics for the prevention of treatment failure in children with complicated appendicitis: has the abandonment of peripherally inserted catheters been justified?","volume":"266","author":"Rangel","year":"2017","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ejps.2025.107159_bib0025","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.3390\/ijms21113935","article-title":"The cell membrane of Sulfolobus spp.\u2014homeoviscous adaption and biotechnological applications","volume":"21","author":"Rast\u00e4dter","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2025.107159_bib0026","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jconrel.2009.08.010","article-title":"Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis","volume":"140","author":"Roger","year":"2009","journal-title":"J. Control Rel."},{"key":"10.1016\/j.ejps.2025.107159_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122632","article-title":"Ether lipids from archaeas in nano-drug delivery and vaccination","volume":"634","author":"Romero","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107159_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2014.00217","article-title":"Vancomycin revisited - 60 years later","volume":"2","author":"Rubinstein","year":"2014","journal-title":"Front. Public Health"},{"key":"10.1016\/j.ejps.2025.107159_bib0029","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.xphs.2020.03.012","article-title":"New insights into the pharmacokinetics of Vancomycin after oral and intravenous administration: an investigation in beagle dogs","volume":"109","author":"Sauter","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107159_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123434","article-title":"Archaeosomes facilitate storage and oral delivery of cannabidiol","volume":"645","author":"Sedlmayr","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107159_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114213","article-title":"Archaeal ether lipids improve internalization and transfection with mRNA lipid nanoparticles","volume":"197","author":"Sedlmayr","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107159_bib0032","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.vascn.2013.07.004","article-title":"Accelerated Caco-2 cell permeability model for drug discovery","volume":"68","author":"Sevin","year":"2013","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejps.2025.107159_bib0033","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/cir842","article-title":"Systemic antibiotic therapy for chronic osteomyelitis in adults","volume":"54","author":"Spellberg","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107159_bib0034","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijpharm.2016.08.040","article-title":"Delivery of copper-chelating Trientine (TETA) to the central nervous system by surface modified liposomes","volume":"512","author":"Tremmel","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107159_bib0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2016.03.031","article-title":"A liposomal formulation for the oral application of the investigational hepatitis B drug Myrcludex B","volume":"103","author":"Uhl","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107159_bib0036","first-page":"111","article-title":"Oral delivery of vancomycin by tetraether lipid liposomes","volume":"108","author":"Uhl","year":"2017","journal-title":"Eur. J. Pharm. Sci. Phospholipids Oral Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107159_bib0037","article-title":"Overcoming the mucosal barrier: tetraether lipid-stabilized liposomal nanocarriers decorated with cell-penetrating peptides enable oral delivery of Vancomycin","volume":"4","author":"Uhl","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejps.2025.107159_bib0038","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3390\/pharmaceutics16060694","article-title":"Archaeosomes for oral drug delivery: from continuous microfluidics production to powdered formulations","volume":"16","author":"Vidakovic","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107159_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2023.102731","article-title":"Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrier","volume":"56","author":"Werner","year":"2024","journal-title":"Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ejps.2025.107159_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202303654","article-title":"Oral delivery of the Vancomycin derivative FU002 by a surface-modified liposomal nanocarrier","volume":"13","author":"Werner","year":"2024","journal-title":"Adv. Healthc. Mater."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725001587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725001587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T10:13:25Z","timestamp":1757844805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725001587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":40,"alternative-id":["S0928098725001587"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107159","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Archaeosomal nanocarriers improve pharmacokinetics and bioavailability of vancomycin after oral administration","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107159"}}